C World Wide Group Holding A Eagle Pharmaceuticals, Inc. Transaction History

C World Wide Group Holding A

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$36.72 - $67.73 $664,705 - $1.23 Million	-18,102 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$66.65 - $83.86 $1.33 Million - $1.67 Million	-19,968 Reduced 52.45%	18,102 $1.26 Million
Q2 2018 Aug 03, 2018	BUY	$51.25 - $76.62 $365,976 - $547,143	7,141 Added 23.09%	38,070 $2.88 Million
Q1 2018 May 03, 2018	SELL	$52.16 - $66.86 $281,559 - $360,910	-5,398 Reduced 14.86%	30,929 $1.63 Million
Q4 2017 Feb 07, 2018	SELL	$49.6 - $60.87 $1.37 Million - $1.69 Million	-27,715 Reduced 43.28%	36,327 $1.94 Million
Q3 2017 Nov 06, 2017	BUY	$46.62 - $60.36 $2.99 Million - $3.87 Million	64,042	64,042 $3.82 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.